Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis

Please cite this paper as: Rodriguez M, Reeves M, Caughey A. Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG 2012;119:1067–1073.

[1]  I. Sinai,et al.  Contraceptive failure in the United States. , 2012, Contraception.

[2]  N. Ford,et al.  Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda , 2011, Annals of Internal Medicine.

[3]  L. van Damme,et al.  Baseline Factors Associated With Incident HIV and STI in Four Microbicide Trials , 2010, Sexually transmitted diseases.

[4]  C. Morrison,et al.  Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling , 2010, AIDS.

[5]  S. Simoens.  Health Economic Assessment: A Methodological Primer , 2009, International journal of environmental research and public health.

[6]  K. Curtis,et al.  Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review , 2009, AIDS.

[7]  James Y. Dai,et al.  Pregnancy, Contraceptive Use, and HIV Acquisition in HPTN 039: Relevance for HIV Prevention Trials Among African Women , 2009, Journal of acquired immune deficiency syndromes.

[8]  T. Taha,et al.  Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Kapiga,et al.  The Value of Site Preparedness Studies for Future Implementation of Phase 2/IIb/III HIV Prevention Trials: Experience From the HPTN 055 Study , 2008, Journal of acquired immune deficiency syndromes.

[10]  J. Baeten,et al.  Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women , 2007, AIDS.

[11]  I. Kleinschmidt,et al.  Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. , 2007, Contraception.

[12]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.

[13]  N. Sewankambo,et al.  Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda , 2003, AIDS.

[14]  S. Kapiga,et al.  The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania , 1998, AIDS.

[15]  J. Callen.  A longitudinal study of human immunodeficiency virus transmission by heterosexual partners: de Vincenzi I for the European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341–346 , 1995 .

[16]  I. de Vincenzi,et al.  A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners , 1994 .

[17]  J. Baeten,et al.  Use of hormonal contraceptives and risk of HIV-1 transmission : a prospective cohort study , 2011 .

[18]  M. Irkec,et al.  Juvenile xanthogranuloma of the corneal limbus: report of two cases and review of the literature. , 2008, Cornea.

[19]  I. Shah,et al.  Unsafe abortion: Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. Sixth edition. , 2004 .

[20]  L. van der Merwe,et al.  Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. , 2002, The Cochrane database of systematic reviews.

[21]  I. de Vincenzi.  A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. , 1994, The New England journal of medicine.

[22]  P. Piot,et al.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. , 1993 .

[23]  G. H. Green.  Trends in maternal mortality. , 1966, The New Zealand medical journal.